Metabolic reprogramming in macrophages and dendritic cells in innate immunityBeth Kelly, Luke O'neill|Cell Research|2015Cited by 1.8k
Targeting Toll-like receptors: emerging therapeutics?Elizabeth J. Hennessy, Luke O'neill|Nature Reviews Drug Discovery|2010Cited by 883
Trained immunity, tolerance, priming and differentiation: distinct immunological processesMaziar Divangahi, Mihai G. Netea, Peter Aaby et al.|Nature Immunology|2020Cited by 591
The Immunomodulatory Metabolite Itaconate Modifies NLRP3 and Inhibits Inflammasome ActivationAlexander Hooftman, Luke O'neill|Cell Metabolism|2020Cited by 571
Targeting immunometabolism as an anti-inflammatory strategyEva M. Pålsson‐McDermott, Luke O'neill|Cell Research|2020Cited by 552